<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">627904</article-id><article-id pub-id-type="doi">10.18565/aig.2023.251</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Placenta accreta: a modern view on etiopathogenesis and obstetric tactics</article-title><trans-title-group xml:lang="ru"><trans-title>Врастание плаценты: современный взгляд на вопросы этиопатогенеза и акушерской тактики. Акушерство и гинекология ФГАОУ ВО</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9945-3848</contrib-id><name-alternatives><name xml:lang="en"><surname>Ignatko</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Игнатко</surname><given-names>Ирина Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Med. Sci., Corresponding Member of the Russian Academy of Sciences, Professor of the Russian Academy of Sciences, Professor, Head of the Department of Obstetrics, Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, чл.-корр. РАН, профессор РАН, профессор, заведующий кафедрой акушерства, гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>ignatko_i_v@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1156-7726</contrib-id><name-alternatives><name xml:lang="en"><surname>Bogomazova</surname><given-names>Irina M.</given-names></name><name xml:lang="ru"><surname>Богомазова</surname><given-names>Ирина Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor, Associate Professor of the Department of Obstetrics, Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, доцент, доцент кафедры акушерства, гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>bogomazova_i_m@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6628-0023</contrib-id><name-alternatives><name xml:lang="en"><surname>Timokhina</surname><given-names>Elena V.</given-names></name><name xml:lang="ru"><surname>Тимохина</surname><given-names>Елена Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Med. Sci., Associate Professor, Professor of the Department of Obstetrics, Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, доцент, профессор кафедры акушерства, гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>timokhina_i_m@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8332-7073</contrib-id><name-alternatives><name xml:lang="en"><surname>Belousova</surname><given-names>Vera S.</given-names></name><name xml:lang="ru"><surname>Белоусова</surname><given-names>Вера Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Med. Sci., Associate Professor, Professor of the Department of Obstetrics, Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, доцент, профессор кафедры акушерства, гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>belousova_v_s@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9661-5338</contrib-id><name-alternatives><name xml:lang="en"><surname>Fedyunina</surname><given-names>Irina A.</given-names></name><name xml:lang="ru"><surname>Федюнина</surname><given-names>Ирина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Associate Professor of the Department of Obstetrics, Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры акушерства, гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>fedyunina_i_m@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4315-0717</contrib-id><name-alternatives><name xml:lang="en"><surname>Kardanova</surname><given-names>Madina A.</given-names></name><name xml:lang="ru"><surname>Карданова</surname><given-names>Мадина Аслановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, Assistant of the Department of Obstetrics, Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, ассистент кафедры акушерства, гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>kardanova_i_m@staff.sechenov.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8266-6524</contrib-id><name-alternatives><name xml:lang="en"><surname>Samara</surname><given-names>Alina B.</given-names></name><name xml:lang="ru"><surname>Самара</surname><given-names>Алина Байяновна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>student of the N.V. Sklifosovsky Institute of Clinical Medicine</p> <p> </p></bio><bio xml:lang="ru"><p>студентка Института клинической медицины им. Н.В. Склифосовского</p> <p> </p></bio><email>linaasamaraa@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-3712-3280</contrib-id><name-alternatives><name xml:lang="en"><surname>Gutsu</surname><given-names>Vladimir</given-names></name><name xml:lang="ru"><surname>Гуцу</surname><given-names>Владимир</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Resident of the Department of Obstetrics; Gynecology and Perinatology of the N.V. Sklifosovsky Institute of Clinical Medicine</p></bio><bio xml:lang="ru"><p>ординатор кафедры акушерства; гинекологии и перинатологии Института клинической медицины им. Н.В. Склифосовского</p></bio><email>gutsu_vladimir@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">«Первый Московский государственный медицинский университет имени И.М. Сеченова» Министерства здравоохранения Российской Федерации (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-01-31" publication-format="electronic"><day>31</day><month>01</month><year>2024</year></pub-date><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>5</fpage><lpage>11</lpage><history><date date-type="received" iso-8601-date="2024-03-01"><day>01</day><month>03</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-03-01"><day>01</day><month>03</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, ООО «Бионика Медиа»</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/627904">https://journals.eco-vector.com/0300-9092/article/view/627904</self-uri><abstract xml:lang="en"><p>Placenta accreta spectrum refers to a form of abnormal placentation and its severity depends on the depth of trophoblast invasion. This abnormality leads to a partial or complete delay in the separation of the placenta in the third stage of labor. The incidence of placental attachment disorders has increased by more than 9 times over the past 20 years. The etiological factors of the abnormality include placenta previa, the presence of postoperative uterine scar, the history of intrauterine interventions, pelvic inflammatory diseases, etc. Placenta previa and uterine scar after cesarean section (CS) are the most common causes of placenta accreta; moreover, the risk of placenta accreta after one CS increases by 7 times, and it increases by 56 times after two or more CS.</p> <p>Currently, the main theory on the pathogenesis of placenta accreta consists in an impaired decidualization of the endometrium, which leads to uncontrolled invasion of the trophoblast. It is the decidua basalis that regulates proper invasion of the trophoblast by producing pro- and anti-invasive factors. This review presents the evolution of placenta accreta classifications. The main methods of antenatal diagnosis of placenta accreta are ultrasound assessment and magnetic resonance imaging, but none of them has 100% sensitivity and specificity; therefore, laboratory studies are currently conducted to search for biomarkers associated with the depth of trophoblast invasion.</p> <p><bold>Conclusion: </bold>The tactics of managing patients with placenta accreta depends on the depth of invasion, the amount of blood loss and the experience of surgeons, as well as the woman’s desire to preserve her fertility. There are conservative or organ-preserving methods of surgical treatment and non-conservative ones which include hysterectomy. The conservative methods include leaving the placenta <italic>in situ</italic>, one-stage surgical management, and the Triple-P procedure. The traditional technique involving CS followed by hysterectomy is characterized by a high maternal morbidity due to the development of intra- and postoperative complications.</p></abstract><trans-abstract xml:lang="ru"><p>Врастание плаценты (Placenta Accreta Spectrum) относится к форме аномальной плацентации по глубине инвазии трофобласта, приводящей к частичной или полной задержке отделения плаценты в третьем периоде родов. За последние 20 лет частота случаев патологического прикрепления плаценты увеличилась более чем в 9 раз. К этиологическим факторам данной аномалии относят предлежание плаценты, наличие на матке послеоперационных рубцов, перенесенные внутриматочные вмешательства, инфекционно-воспалительные заболевания органов малого таза и другие. Среди наиболее частых причин фигурируют предлежание плаценты и рубец на матке после кесарева сечения (КС); причем если риск врастания плаценты после одного КС увеличивается в 7 раз, то после двух и более – в 56 раз. В настоящее время основной патогенетической теорией врастания плаценты является нарушение децидуализации эндометрия, что приводит к неконтролируемой инвазии трофобласта. Именно децидуальная оболочка (decidua basalis), осуществляя выработку про- и антиинвазивных факторов, регулирует адекватную инвазию трофобласта. В данном обзоре представлена эволюция классификаций врастания плаценты. Основными методами антенатальной диагностики врастания плаценты являются ультразвуковое исследование и магнитно-резонансная томография, однако ни один из них не обладает 100% чувствительностью и специфичностью, поэтому в настоящее время проводятся лабораторные исследования, направленные на поиск биомаркеров, ассоциированных с глубиной инвазии трофобласта.</p> <p><bold>Заключение: </bold>Тактика ведения пациенток с врастанием плаценты зависит от глубины инвазии, объема кровопотери и опыта хирургов, а также желания женщины сохранить репродуктивную функцию. Различают консервативные, или органосохраняющие, методы хирургического лечения и неконсервативные, к которым относится гистерэктомия. Среди консервативных методов выделяют оставление плаценты <italic>in situ</italic>, одноэтапную консервативную хирургическую тактику и процедуру Triple-P. Традиционная методика, предполагающая КС с последующей гистерэктомией, характеризуется высокой материнской заболеваемостью вследствие развития интра- и послеоперационных осложнений.</p></trans-abstract><kwd-group xml:lang="en"><kwd>placenta accreta</kwd><kwd>placenta increta</kwd><kwd>placenta percreta</kwd><kwd>PAS</kwd><kwd>etiology of placenta accreta</kwd><kwd>classification of placenta accreta</kwd><kwd>diagnosis of placenta accreta</kwd><kwd>conservative treatment of placenta accreta</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>врастание плаценты</kwd><kwd>placenta accreta</kwd><kwd>placenta increta</kwd><kwd>placenta percreta</kwd><kwd>PAS</kwd><kwd>этиология врастания плаценты</kwd><kwd>классификация врастания плаценты</kwd><kwd>диагностика врастания плаценты</kwd><kwd>консервативное лечение врастания плаценты</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hecht J.L., Baergen R., Ernst L.M., Katzman P.J., Jacques S.M., Jauniaux E. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. Mod. Pathol. 2020;33(12):2382-96. https://dx.doi.org/10.1038/s41379-020-0569-1.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Arakaza A., Zou L., Zhu J. Placenta accrete spectrum diagnosis challenges and controversies in current obstetrics: a review. Int. J. Womens Health. 2023;15:635-54. https://dx.doi.org/10.2147/IJWH.S395271.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Jauniaux E., Bhide A., Kennedy A., Woodward P., Hubinont C., Collins S.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int. J. Gynaecol. Obstet. 2018;140(3):274-80. https://dx.doi.org/10.1002/ijgo.12408.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Berkley E.M., Abuhamad A. Imaging of placenta accreta spectrum. Clin. Obst. Gynecol. 2018;61(4):755-65. https://dx.doi.org/10.1097/GRF.0000000000000407.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jauniaux E., Chantraine F., Silver R.M., Langhoff-Roos J.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int. J. Gynaecol. Obstet. 2018;140(3):265-73. https://dx.doi.org/10.1002/ijgo.12407.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Забелина Т.М., Васильченко О.Н., Каримова Г.Н., Ежова Л.С., Учеваткина П.В., Шмаков Р.Г. Родоразрешение беременных с врастанием плаценты без рубца на матке. Акушерство и гинекология. 2021;4: 150-6. [Zabelina T.M., Vasilchenko O.N., Karimova G.N., Ezhova L.S., Uchevatkina P.V., Shmakov R.G. Delivery of pregnant women with placenta increta and no uterine scar. Obstetrics and Gynecology. 2021;(4):150-6. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.4.150-156.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Организация объединенных наций. Новости ООН, 16 июня 2021. ВОЗ: все больше женщин рожают с помощью кесарева сечения при отсутствии медицинских показаний. Доступно по: http://news.un.org/ru/story/2021/06/1404792. [United Nations. UN News, 2021, June 16. WHO: more and more women are giving birth by caesarean section in the absence of medical indications. Available at: http://news.un.org/ru/story/2021/06/1404792. (in Russian)].</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Betran A.P., Ye J., Moller A.B., Souza J.P., Zhang J. Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob. Health. 2021;6(6):e005671. https://dx.doi.org/10.1136/bmjgh-2021-005671.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>The Lancet. Stemming the global caesarean section epidemic. Lancet. 2018;392(10155):1279. https://dx.doi.org/10.1016/S0140-6736(18)32394-8.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Thurn L., Lindqvist P.G., Jakobsson M., Colmorn L.B., Klungsoyr K., Bjarnadóttir R.I. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2016;123(8):1348-55. https://dx.doi.org/10.1111/1471-0528.13547.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Marshall N.E., Fu R., Guise J.M. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am. J. Obstet. Gynecol. 2011;205(3):262.e1-8. https://dx.doi.org/10.1016/j.ajog.2011.06.035.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Jauniaux E., Collins S., Burton G.J. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am. J. Obstet. Gynecol. 2018;218(1):75-87. https://dx.doi.org/10.1016/ j.ajog.2017.05.067.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Morlando M., Collins S. Placenta accreta spectrum disorders: challenges, risks, and management strategies. Int. J. Womens Health. 2020;12:1033-45. https://dx.doi.org/10.2147/IJWH.S224191.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Badr D.A., Al Hassan J., Wehbe G.S., Ramadan M.K. Uterine body placenta accreta spectrum: A detailed literature review. Placenta. 2020;95:44-52. https://dx.doi.org/10.1016/j.placenta.2020.04.005.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Sharma S., Godbole G., Modi D. Decidual control of trophoblast invasion. Am. J. Reprod. Immunol. 2016;75(3):341-50. https://dx.doi.org/10.1111/aji.12466</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Zhang X., Wei H. Role of decidual natural killer cells in human pregnancy and related pregnancy complications. Front. Immunol. 2021;12:728291. https://dx.doi.org/10.3389/fimmu.2021.728291.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Laban M., Ibrahim E.A., Elsafty M.S., Hassanin A.S. Placenta accreta is associated with decreased decidual natural killer (dNK) cells population: a comparative pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014;181:284-8. https://dx.doi.org/10.1016/j.ejogrb.2014.08.015.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Carlino C., Rippo M.R., Lazzarini R., Monsurrò V., Morrone S., Angelini S. et al. Differential microRNA expression between decidual and peripheral blood natural killer cells in early pregnancy. Hum. Reprod. 2018;33(12):2184-95. https://dx.doi.org/10.1093/humrep/dey323</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Jansen C.H.J.R., Kastelein A.W., Kleinrouweler C.E., van Leeuwen E., De Jong K.H., Pajkrt E., van Noorden C.J.F. Development of placental abnormalities in location and anatomy. Acta Obstet. Gynecol. Scand. 2020;99(8):983-93. https://dx.doi.org/10.1111/aogs.13834</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Qian Z.-D, Weng Y., Wang C.-F., Huang L.-L., Zhu X.-M. Research on the expression of integrin β3 and leukaemia inhibitory factor in the decidua of women with cesarean scar pregnancy. BMC Pregnancy Childbirth. 2017;17(1):84. https://dx.doi.org/10.1186/s12884-017-1270-3.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Torabi S., Sheikh M., Masrour F.F., Shamshirsaz A.A., Bateni Z.H., Nassr A.A. et al. Uterine artery Doppler ultrasound in second pregnancy with previous elective cesarean section. J. Matern. Fetal Neonatal Med. 2019;32(13):2221-7. https://dx.doi.org/10.1080/14767058.2018.1430132.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Flo K., Widnes C., Vårtun Å., Acharya G. Blood flow to the scarred gravid uterus at 22–24 weeks of gestation. BJOG. 2014;121(2):210-5. https://dx.doi.org/10.1111/1471-0528.12441.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Shigemitsu A., Naruse K., Kobayashi H. Hypoxia promotes extravillous trophoblast cell invasion through the hypoxia-inducible factor urokinase-type plasminogen activator receptor pathway. Gynecol. Obstet. Invest. 2022;87(3-4):232-41. https://dx.doi.org/10.1159/000525851.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Zhao H., Wong R.J., Stevenson D.K. The impact of hypoxia in early pregnancy on placental cells. Int. J. Mol. Sci. 2021;22(18):9675. https://dx.doi.org/10.3390/ijms22189675.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Jauniaux E., Ayres-de-Campos D., Langhoff-Roos J., Fox K.A., Collins S.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. Int. J. Gynaecol. Obstet. 2019;146(1):20-4. https://dx.doi.org/10.1002/ijgo.12761.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Palacios-Jaraquemada J.M., D'Antonio F., Buca D., Fiorillo A., Larraza P. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. J. Matern. Fetal Neonatal Med. 2020;33(19):3377-84. https://dx.doi.org/ 10.1080/14767058.2019.1570494.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Maged A.M., El-Mazny A., Kamal N., Mahmoud S.I., Fouad M., El-Nassery N. et al. Diagnostic accuracy of ultrasound in the diagnosis of placenta accreta spectrum: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023;23(1):354. https://dx.doi.org/10.1186/s12884-023-05675-6.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>De Oliveira Carniello M., Oliveira Brito L.G., Sarian L.O., Bennini J.R. Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2022;59(4):428-36. https://dx.doi.org/10.1002/uog.24861.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>D'Antonio F., Iacovella C., Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2013;42(5):509-17. https://dx.doi.org/10.1002/uog.13194.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bailit J.L., Grobman W.A., Rice M.M., Reddy U.M., Wapner R.J., Varner M.W. et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet. Gynecol. 2015;125(3):683-9. https://dx.doi.org/10.1097/AOG.0000000000000680.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Tinari S., Buca D., Cali G., Timor-Tritsch I., Palacios-Jaraquemada J., Rizzo G. et al. Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 2021;57(6):903-9. https://dx.doi.org/10.1002/uog.22183</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Morel O., Collins S.L., Uzan-Augui J., Masselli G., Duan J., Chabot-Lecoanet A.C. et al.; International Society for Abnormally Invasive Placenta (IS-AIP). A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP) – from the International Society for AIP. Diagn. Interv. Imaging. 2019;100(6):319-25. https://dx.doi.org/10.1016/ j.diii.2019.02.004.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Familiari A., Liberati M., Lim P., Pagani G., Cali G., Buca D. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet. Gynecol. Scand. 2018;97(5):507-20. https://dx.doi.org/10.1111/aogs.13258.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Einerson B.D., Rodriguez C.E., Kennedy A.M., Woodward P.J., Donnelly M.A., Silver R.M. Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders. Am. J. Obstet. Gynecol. 2018;218(6):618.e1-618.e7. https://dx.doi.org/10.1016/j.ajog.2018.03.013.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Zhang T., Wang S. Potential serum biomarkers in prenatal diagnosis of placenta accreta spectrum. Front. Med. (Lausanne). 2022;9:860186. https://dx.doi.org/10.3389/fmed.2022.860186.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Виницкий А.А., Шмаков Р.Г. Современные представления об этиопатогенезе врастания плаценты и перспективы его прогнозирования молекулярными методами диагностики. Акушерство и гинекология. 2017;2: 5-10. [Vinitskiy A.A., Shmakov R.G. The modern concepts of etiology and pathogenesis placenta accreta and prospects of its prediction by molecular diagnostics. Obstetrics and Gynecology. 2017;(2):5-10. (in Russian)]. https://dx.doi.org/10.18565/aig.2017.2.5-10.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Rac M.W.F., Dashe J.S., Wells C.E., Moschos E., McIntire D.D., Twickler D.M. Ultrasound predictors of placental invasion: the placenta accreta index. Am. J. Obstet. Gynecol. 2015;212(3):343.e1-7. https://dx.doi.org/10.1016/ j.ajog.2014.10.022.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Jauniaux E., Hussein A.M., Fox K.A., Collins S.L. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract. Res. Clin. Obstet. Gynaecol. 2019;61:75-88. https://dx.doi.org/10.1016/ j.bpobgyn.2019.04.006.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Sentilhes L., Kayem G., Chandraharan E., Palacios-Jaraquemada J., Jauniaux E.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int. J. Gynaecol. Obstet. 2018;140(3):291-8. https://dx.doi.org/10.1002/ijgo.12410.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Sentilhes L., Kayem G., Silver R.M. Conservative management of placenta accreta spectrum. Clin. Obstet. Gynecol. 2018;61(4):783-94. https://dx.doi.org/10.1097/GRF.0000000000000395.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>de Marcillac F.D., Lecointre L., Guillaume A., Sananes N., Fritz G., Viville B. et al. Morbimortalité maternelle associée au traitement conservateur d’un placenta anormalement adhérent (accreta) diagnostiqué en anténatal. À propos d’une série continue de 15 cas [Maternal morbidity and mortality associated with conservative management for placenta morbidly adherent (accreta) diagnosed during pregnancy. Report of 15 cases]. J. Gynecol. Obstet. Biol. Reprod. (Paris). 2016;45(8):849-58. French. https://dx.doi.org/10.1016/j.jgyn.2016.03.012.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Курцер М.А., Бреслав И.Ю., Латышкевич О.А., Григорьян А.М. Временная баллонная окклюзия общих подвздошных артерий у пациенток с рубцом на матке после кесарева сечения и placenta accreta. Преимущества и возможные осложнения. Акушерство и гинекология. 2016;12: 70-5. [Kurtser M.A., Breslav I.Yu., Latyshkevich O.A., Grigoryan A.M. Temporary balloon occlusion of the common iliac arteries in patients with post-cesarean uterine scar and placenta accreta: Advantages and possible complications. Obstetrics and Gynecology. 2016;(12):70-5. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.12.70-5.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Allen L., Jauniaux E., Hobson S., Papillon-Smith J., Belfort M.A.; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int. J. Gynaecol. Obstet. 2018;140(3):281-90. https://dx.doi.org/10.1002/ijgo.12409.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Piñas Carrillo A., Chandraharan E. Placenta accreta spectrum: Risk factors, diagnosis and management with special reference to the Triple P procedure. Womens Health (Lond). 2019;15:1745506519878081. https://dx.doi.org/10.1177/1745506519878081.</mixed-citation></ref></ref-list></back></article>
